# SymlinPen

NDC: 0310-6627
Generic name: pramlintide acetate
Labeler / Manufacturer: AstraZeneca Pharmaceuticals LP
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: New Drug Application (innovator)
Dosage form: INJECTION
Routes: SUBCUTANEOUS
Marketing started: 20150108
Marketing ended: 20270131
FDA application: NDA021332

## Active ingredients

- PRAMLINTIDE ACETATE: 1000 ug/mL

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"0310-6627"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=0310-6627
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=4aea30ff-eb0d-45c1-b114-3127966328ff